FRAMINGHAM, MA — The US Food and Drug Administration issued a formal warning to the makers of a recently approved ventricular assist device (VAD) system (HeartWare, Framingham, MA) for failing to take ...
In a letter to healthcare providers, the US Food and Drug Administration said today that Medtronic has ceased the sale and distribution of its HeartWare ventricular assist device (HVAD) system. The ...
As one of two major players in the left ventricular assist device (LVAD) market, HeartWare has been seen as an acquisition target in the past. In fact, LVAD pioneer and HeartWare competitor Thoratec ...
After three strikes in just the last six months, Medtronic’s implantable heart pump is out. The company issued (PDF) an urgent message Thursday notifying doctors and patients that it would immediately ...
MedPage Today on MSN
The Chase Is Still On in Heart Pump Innovation
New concepts in device therapy for advanced heart failure presented in early reports ...
After issuing near-monthly safety warnings related to its discontinued HeartWare Ventricular Assist Device (HVAD) last year, Medtronic is already continuing the trend in 2023. The heart pump’s first ...
SALT LAKE CITY- Surgeons at University of Utah Hospital have performed the hospital’s first implant of a new generation left ventricular assist device (LVAD) using the HeartWare HVAD. The tiny, ...
FRAMINGHAM, Mass., HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results